In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...

Probability and Statistics Group research at the School of Mathematical and Computer Sciences at Heriot-Watt University, Edinburgh.